MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

AngioDynamics Company Profile (NASDAQ:ANGO)

Consensus Ratings for AngioDynamics (NASDAQ:ANGO) (?)
Ratings Breakdown: 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $14.10 (4.91% upside)

Analysts' Ratings History for AngioDynamics (NASDAQ:ANGO)
Show:
DateFirmActionRatingPrice TargetActions
4/8/2016KeyBancLower Price TargetOverweight$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Piper JaffrayInitiated CoverageNeutral$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016Canaccord GenuityDowngradeBuy -> Hold$14.50 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Raymond JamesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2015SidotiInitiated CoverageNeutral$14.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for AngioDynamics (NASDAQ:ANGO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/14/2016        
4/7/2016Q3$0.14$0.15$87.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/7/2016Q216$0.14$0.14$88.67 million$89.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/8/2015Q116$0.11$0.11$83.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/16/2015Q415$0.14$0.14$91.67 million$90.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/9/2015Q315$0.16$0.12$86.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/8/2015Q215$0.15$0.17$90.90 million$92.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/9/2014Q115$0.11$0.16$87.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q414$0.12$0.18$93.65 million$94.07 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/9/2014Q314$0.09$0.16$86.85 million$88.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/9/2014Q2$0.07$0.14$87.54 million$88.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/10/2013Q114$0.03$0.04$82.54 million$83.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/11/2013Q4 2013$0.06$0.07$86.43 million$90.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/8/2013Q3 2013$0.05$0.08$81.70 million$81.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/3/2013Q2 2013$0.09$0.10$87.40 million$87.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/8/2012Q113$0.09$0.10$84.35 million$83.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/12/2012$0.08$0.09ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/4/2012$0.07$0.09ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/5/2012$0.12$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/6/2011$0.09$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/14/2011$0.10$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/5/2011$0.12$0.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/4/2011$0.12$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for AngioDynamics (NASDAQ:ANGO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.12$0.15$0.14
Q2 20162$0.16$0.17$0.17
(Data provided by Zacks Investment Research)
Dividend History for AngioDynamics (NASDAQ:ANGO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for AngioDynamics (NASDAQ:ANGO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/6/2016Charles R GreinerVPSell3,508$12.31$43,183.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2016Stephen A TrowbridgeSVPSell12,940$12.30$159,162.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Matthew KapustaSVPBuy1,000$13.90$13,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013Vincent BucciDirectorBuy5,000$15.20$76,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/17/2013Howard W DonnellyDirectorSell20,000$15.06$301,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2013Kevin J GouldDirectorBuy2,700$12.00$32,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2013Charles R GreinerVPSell1,495$10.38$15,518.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2013Vincent BucciDirectorBuy85,000$10.77$915,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2013Vincent BucciDirectorBuy2,000$12.17$24,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/11/2013Kevin J GouldDirectorBuy2,700$11.58$31,266.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2012Jeffrey GoldDirectorBuy1,000$10.56$10,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for AngioDynamics (NASDAQ:ANGO)
DateHeadline
06/17/16 04:05 PMETF’s with exposure to AngioDynamics, Inc. : June 17, 2016 -
06/14/16 09:18 AMAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2016 By the Numbers : June 14, 2016 -
05/18/16 07:17 AMAngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : May 18, 2016 -
04/28/16 11:24 AMPAVmed Inc. (Nasdaq: PAVMU) to Ring The Nasdaq Stock Market Opening Bell - [at noodls] - ADVISORY, April 28, 2016 (GLOBE NEWSWIRE) -- What: PAVmed Inc. (Nasdaq:PAVMU), a multi-product medical device company bringing innovative medical technologies from concept to commercialization with unprecedented ...
04/28/16 06:15 AMAngioDynamics releases details of ex-CEO's severance package -
04/27/16 03:16 PMANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits -
04/21/16 08:20 AM2 more executives leave one of Albany's biggest public companies -
04/21/16 08:08 AMNew AngioDynamics CEO: I'll focus on current business now, M&A next phase -
04/20/16 09:57 AMAngioDynamics finance chief bids adieu, commercial chief axed -
04/20/16 07:51 AMANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers -
04/14/16 01:47 PMETF’s with exposure to AngioDynamics, Inc. : April 14, 2016 -
04/13/16 08:24 AMAngioDynamics, Inc. :ANGO-US: Earnings Analysis: Q3, 2016 By the Numbers -
04/12/16 02:23 PMAngioDynamics, Inc. – Value Analysis (NASDAQ:ANGO) : April 12, 2016 -
04/11/16 07:15 AMAngioDynamics, Inc. breached its 50 day moving average in a Bearish Manner : ANGO-US : April 11, 2016 -
03/29/16 05:53 AMAngioDynamics To Report Fiscal 2016 Third Quarter Financial Results - ALBANY, N.Y., March 29, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report ...
03/10/16 05:30 AMAngioDynamics and Merz North America Establish Multi-Year Relationship to Market Asclera for Vein Patients - [GlobeNewswire] - ALBANY, N.Y., March 10, 2016-- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today ...
03/07/16 07:04 AMAngioDynamics, Inc. breached its 50 day moving average in a Bullish Manner : ANGO-US : March 7, 2016 -
03/07/16 05:30 AMAngioDynamics to Present at the Barclays Global Healthcare Conference - [GlobeNewswire] - ALBANY, N.Y., March 07, 2016-- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today ...
02/16/16 08:21 AMStrong Investor Participation and Presentations at Long Island Capital Alliance Healthcare Capital Forum - [Marketwired] - The Long Island Capital Alliance , Long Island's leading non-profit capital formation and business development organization, today announced the successful completion of its Healthcare Capital Forum held ...
02/10/16 01:30 PMGov. Cuomo seeks to reframe $15 billion cost of minimum wage as 'reinvestment' -
02/09/16 03:20 PMAngioDynamics: Health Canada Okays Celerity with Navigation -
02/09/16 01:32 PMAngioDynamics wins Health Canada nod for new Celerity device - AngioDynamics (NSDQ:ANGO) said today that it won approval from Health Canada ... CCSI Distributors, a subsidiary of Clinical Computer Systems Inc., announced their partnership with OB-Tools. This relationship provides exclusive distribution rights for ...
02/08/16 05:31 AM6:31 am AngioDynamics announces Health Canada approval of the Celerity PICC Tip Confirmation System with navigation -
02/08/16 05:30 AMAngioDynamics Announces the Approval of the Celerity PICC Tip Confirmation System With Navigation in Canada - [GlobeNewswire] - ALBANY, N.Y., Feb. 08, 2016-- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today ...
01/20/16 10:10 AMAngioDynamics, Inc. Earnings Analysis: Q2, 2016 By the Numbers -
01/14/16 12:04 PMANGIODYNAMICS INC Financials -
01/13/16 09:28 AMANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
01/12/16 11:14 AMMauna Kea Technologies Announces the Appointment of Joseph DeVivo as a Non-Executive Director - [at noodls] - , /PRNewswire/ -- (Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced the appointment of as a Director. is the President ...
01/08/16 03:31 PMANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report -
01/08/16 08:20 AMAngioDynamics Q2 Earnings In Line, Sales Top; '16 View Cut -
01/07/16 09:32 PMEdited Transcript of ANGO earnings conference call or presentation 7-Jan-16 9:30pm GMT -
01/07/16 03:20 PMAngioDynamics Reports Fiscal 2016 Second Quarter Results - [at noodls] - January 7, 2016 Net sales of GAAP loss of per share; Non-GAAP adjusted EPS of Operating cash generation of , (GLOBE NEWSWIRE) -- (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical ...
01/07/16 03:19 PMANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit -
01/07/16 03:13 PMAngioDynamics reports 2Q loss -
01/07/16 06:07 AMQ2 2016 AngioDynamics Inc Earnings Release - After Market Close -
01/04/16 05:58 AMAngioDynamics to Present at the 34th Annual J.P. Morgan Global Healthcare Conference - [at noodls] - January 4, 2016 , (GLOBE NEWSWIRE) -- (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced ...
About AngioDynamics

AngioDynamics logoAngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include fluid management, venous, thrombus management, as well as other core products. The Company's BioFlo products incorporate Endexo technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its microwave ablation products, its radiofrequency ablation (RFA) and its NanoKnife product lines.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ANGO
  • CUSIP: 03475V10
Key Metrics:
  • Previous Close: $13.96
  • 50 Day Moving Average: $12.68
  • 200 Day Moving Average: $11.80
  • P/E Ratio: N/A
  • P/E Growth: 1.39
  • Market Cap: $486.85M
  • Current Quarter EPS Consensus Estimate: $0.56 EPS
Additional Links:
AngioDynamics (NASDAQ:ANGO) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha